Adenocarcinoma comprises 80% of non-small cell lung cancer (NSCLC), and epidermal growth factor receptor (EGFR) mutations mostly appear in this subtype (2, 3). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.